Examination of the kidneys in a diabetic patient

Česká verzia

Authors: V. Tesař
Authors place of work: Klinika nefrologie 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Vladimír Tesař, DrSc.
Published in the journal: Vnitř Lék 2008; 54(5): 494-498
Category:

Summary

Diabetic nephropathy is the most frequent cause of terminal renal failure in the Czech Republic today. Diabetic patients should be screened for diabetic kidney disease on an annual basis, starting 5 years after diabetes was diagnosed in type 1 diabetes patients and immediately after diagnosis in type 2 diabetes patients. The screening includes determining the albumin/creatinine ratio from a urine sample, and of serum creatinine, and the calculation of glomerular filtration rate. In patients in whom microalbuminuria and/or proteinuria were found, measures should be taken to reduce cardiovascular risk and to slow down the progression of renal disease. In diabetic patients with abnormal urine test results detailed nephrology examination is necessary to exclude other renal diseases than diabetic nephropathy, especially chronic glomerulonephritis and ischaemic nephropathy.

Key words:
diabetes mellitus – diabetic nephropathy – albuminuria – proteinuria – albumin/creatinine ratio

Zdroje

1. American Diabetes Association: Clinical Practice Recommendations 2005. Diabetes Care 2005; 28(Suppl 1): S1-S79.

2. Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 2006; 47: 927-946.

3. Costacou T, Ellis D, Fried L et al. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 2007; 50: 721-732.

4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.

5. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41(Suppl 3): S1-S91.

6. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(Suppl 3): S1-S153.

7. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49(Suppl 2): S1-S154.

8. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.

9. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004; 27: 195-200.

10. Pham TT, Sim JJ, Kujubu DA et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007; 27: 322-328.

11. Rigalleau V, Lasseur C, Raffaitin C et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care 2007; 30: 2034-2039.

12. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria. Kidney Int 2006; 70: 1214-1222.

13. Vora JP et al. Clinical manifestations and natural history of diabetic nephropathy. In: Johnson RJ, Feehally J. Comprehensive clinical nephrology. London: Mosby 2000: 34.1.-34.12.